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ABSTRACT
The HIV-1 TAR RNA represents a well-known para-
digm to study the role of dynamics and conforma-
tional change in RNA function. This regulatory RNA
changes conformation in response to binding of Tat
protein and of a variety of peptidic and small mole-
cule ligands, indicating that its conformational flex-
ibility and intrinsic dynamics play important roles
in molecular recognition. We have used 13C NMR
relaxation experiments to examine changes in the
motional landscape of HIV-1 TAR in the presence
of three ligands of different affinity and specificity.
The ligands are argininamide, a linear peptide mimic
of the Tat basic domain and a cyclic peptide that
potently inhibits Tat-dependent activation of tran-
scription. All three molecules induce the same
motional characteristics within the three nucleo-
tides bulge that represents the Tat-binding site.
However, the cyclic peptide has a unique motional
signature in the apical loop, which represents a
binding site for the essential host co-factor cyclin
T1. These results suggest that all peptidic mimics
of Tat induce the same dynamics in TAR within
this protein binding site. However, the new cyclic
peptide mimic of Tat represents a new class of
ligands with a unique effect on the dynamics and
the structure of the apical loop.
INTRODUCTION
Many of RNA functional roles depend on its ability to
change structure upon binding of small molecules, pep-
tides or proteins (1–4). This observation suggests that
many RNAs possess intrinsic dynamic features which
expand their functional potential beyond what their lim-
ited chemical repertoire would otherwise allow. This
behavior is evident in the HIV-1 TAR RNA (Figure 1),
one of the ﬁrst systems where the role of conformational
change on RNA function became clear (5–7). TAR is a
conserved stem-loop found at the 50-end of all viral tran-
scripts. It folds immediately after transcriptional initiation
oﬀ the HIV promoter to provide a structure that recruits
the HIV protein Tat and the cyclin T1/cdk9 kinase com-
plex to promote eﬃcient transcriptional elongation (6).
The importance of the Tat–TAR interaction for viral
replication has led to considerable interest in discovering
new inhibitors of viral replication that function by disrupt-
ing the formation of this complex. Many diﬀerent ligands,
ranging from small molecules to peptide mimetics (5,8–11)
have been produced that bind to TAR at the Tat-binding
site. The structures of these complexes have conﬁrmed
that TAR dramatically changes its structure in order to
promote ligand binding (5,6,12). However, none of these
compounds have so far progressed even to the pre-clinical
stage of drug development.
Binding of Tat and the subsequent recruitment of cyclin
T1 and transcriptional activation depend on the ability of
TAR to alter its structure in response to ligand binding.
A single amino acid (argininamide) induces the same con-
formational change in TAR that is observed in much
larger peptide mimics of Tat protein (6,13). The binding
site of Tat is a three nucleotide UCU bulge (U23–U25)
that, once bound to argininamide, causes the U23 residue
to move near to the A27 and U38 base pair, while C24 and
U25 become extrahelical (6).
Given the importance of conformational change to the
function of TAR, the dynamics of TAR have been inves-
tigated in its ligand-free state using both conventional
NMR relaxation measurements and residual dipolar cou-
plings. Multiple studies of the interaction of TAR with
metal ions and small molecular weight ligands have
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suggested that diﬀerent ligands occupy distinct spots in a
trajectory separating two extreme conformational states
(14,15). However, it is still not clear what role motion
may play in ligand binding and how dynamics relate to
complex stability because only ligand-free TAR and its
complex with arginineamide have been systematically
investigated.
In this article, we systematically examine how the
dynamics of TAR change in the presence of ligands of
diﬀerent molecular weight, aﬃnity and speciﬁcity by mea-
suring 13C NMR relaxation and R1r power dependence
for the bases and riboses in the RNA. In addition, we
employ the elongation-method technique to establish
that inter-helical motions that occur around the bulge in
free TAR are quenched in all of the complexes. We inves-
tigate how RNA dynamics at diﬀerent sites correlate with
activity for ligands that bind weakly (argininamide with
a Kd=1mM) (5) or more potently (a nM-binding linear
peptide mimic of Tat protein, Figure 1b) or both more
potently and more speciﬁcally (a nM-binding cyclic pep-
tide mimic of Tat protein), Figure 1c. Relaxation param-
eters (16) (T1, T1r, NOE) dependent on the underlying
internal motions present in free TAR and in these three
distinct complexes are interpreted using the model-free
formalism (17,18). Combined, these measurements and
their analysis are sensitive to internal motions on the
ns–ps and ms–ms timescale, and to global motions on
the ns timescale. The results conﬁrm that unbound TAR
is highly dynamic in both the bulge and apical loop.
Interestingly, ligand binding does not uniformly rigidify
the complex and indeed some sites even become more ﬂex-
ible in the bound forms of TAR. While all complexes dis-
play very similar motional properties at the Tat-binding
site, the cyclic peptide has unique dynamic features in the
apical loop that may correlate with its increased speciﬁ-
city. Thus, ligand binding to TAR leads to the formation
of complex motional landscapes that are speciﬁc for dif-
ferent classes of ligands.
MATERIALS AND METHODS
Sample preparation
All RNAs used in this study were prepared enzymatically
via the phage T7 RNA polymerase in vitro transcription
method (19,20) using 13C–15N-labeled nucleotides pur-
chased from Isotec and in house puriﬁed polymerase.
DNA templates were purchased form IDT and included
20-O-methyl groups attached to the last two residues at the
50-end of the template in order to reduce further addition
of nucleotides past the template end. The RNAs were
puriﬁed by denaturing gel electrophoresis followed by
electro-elution and ethanol precipitation. Finally, micro-
dialysis was performed in a 10mM potassium phosphate
buﬀer (pH 6.6) with 0.01mM EDTA. In addition to pre-
paring fully labeled samples, data on free TAR were also
collected on two partially labeled samples containing
either GU or AC-labeled nucleotides to reduce spectral
overlap.
Argininamide was purchased directly from Sigma;
the cyclic L22 peptide used in this study was synthesized
as described (21); the 11-mer Tat derived peptide (Tat11),
47YGRKKRRQRRR57, was synthesized in house with
a PS3 peptide synthesizer using standard fmoc chemis-
try on an arginine resin (22). The peptide was
then cleaved from the resin and puriﬁed. After puriﬁca-
tion, the peptide was characterized using electrospray
MS and quantized using UV–VIS spectroscopy (tyrosine
"275=1405 cm
1mol1).
Complex formation
The three diﬀerent complexes of TAR with argininamide,
with the Tat-derived 11-mer peptide and with the cyclic
peptide (Figure 1) were prepared by slowly titrating the
desired amount of ligand into a TAR sample and running
an HSQC after each addition to observe the progression
in complex formation. The cyclic peptide, argininamide
and the linear Tat 11-mer peptide were added to separate
TAR RNA solutions until complexes of 1.0, 3.5 and 1.2
molar equivalents were reached, respectively. These ratios
were chosen to ensure saturation of the complex given
their respective binding constants.
NMR relaxation experiments
All data collection was performed on a Bruker Avance-
500 instrument in 10mM phosphate buﬀer at pH 6.6 con-
taining 99.9% D2O and at 258C. The data collected for the
free TAR sample were obtained by using a HCN TXI
triple resonance probe. The data for the remainder of
the samples were collected using a cryoprobe.
The assignments of free TAR and TAR bound to argi-
ninamide were taken from previous studies (5,8); assign-
ments for TAR bound to the two diﬀerent peptides were
obtained by collecting 2D NOESY and 3D NOESY-
HSQC spectra which were analyzed using previously pub-
lished methods (23–25).
T1, T1r and heteronuclear NOE experiments (26) were
recorded as a series of 2D NMR spectra where the value
of the relaxation delay, , was varied parametrically. The
two diﬀerent spectral regions probed in this study required
collection of separate sets of T1/T1r experiments. The data
for the bases (C6, C8) were collected with the 13C fre-
quency set at 144.5 ppm, while the sugars (C10) data
were collected with the 13C frequency set at 93 ppm; the
spectral width was 24 ppm for both datasets. T1 experi-
ments were collected with relaxation delays of 10ms,
20ms, 40ms, 80ms, 160ms, 320ms and 500ms; T1p
experiments used relaxation delays of 4ms, 8ms, 12ms,
24ms, 32ms and 48ms. The experiments with the shortest
delay times were repeated for each data set in order to test
the reproducibility of the data. The heteronuclear NOE
experiments required two experiments for each spectral
region. One experiment was performed with initial
proton saturation while the other was performed without
it. The experiments that utilized proton saturation used
a relaxation delay of 2.5 s followed by a 2.5 s saturation
period; the experiments without saturation used a single
relaxation delay time of 5 s.
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Elongated TAR
Intensities of 13C–1H resonances for C10–H10, C6–H6 and
C8–H8 cross peaks were measured at 258C using standard
non-constant time HSQC experiments on the elongated
TAR construct described below (27,28). Peak intensities
were normalized for each labeled nucleotide indepen-
dently. Stem 1 of TAR was elongated by 20 AU base
pairs and then two GC base pairs were added at the end
of the stem-loop to promote transcription. To reduce spec-
tral crowding, only G and C were 13C/15N labeled by using
the appropriate mix of labeled and unlabeled nucleotides.
Power dependence ofT1r
Power dependence experiments were collected similarly to
the previously described T1r experiments by changing only
the spin-lock power. T1r data sets were collected and ana-
lyzed for C10, C6 and C8 resonances at 500MHz using
various spin-lock ﬁeld strengths of 1.2 kHz, 2.6 kHz,
3.5 kHz, 4.5 kHz and 6.6 kHz by modifying the power
level of the spin-lock pulse. Delays of 4ms, 8ms, 12ms,
16ms, 24ms and 28ms were used in place of longer delays
to prevent sample heating.
Data analysis
All NMR data were processed using NMR pipe (29). The
Sparky relaxation ﬁt software was then used to ﬁt the
relaxation data to single exponential decay curves, as pre-
viously described (30), to obtain values for T1 and T1r.
Using the power dependence data, Rex values were esti-
mated as the diﬀerence between R1r (w1!0) and R1r
(w1!1), the inﬁnite spin-lock ﬁeld.
The primary relaxation data were analyzed semi-
quantitatively using the Model-Free approximation as
implemented in Model-Free 4.15 (17,18) and were found
to be 5.9 ns for free TAR; 6.4 ns for the arginine complex;
7.2 and 7.6 ns, respectively, for the linear and cyclic pep-
tide complex. After determining global rotational correla-
tion times, the relaxation parameters were ﬁt to one of
ﬁve diﬀerent models (30,31), in order to calculate order
parameters for each individual residue. Parameters were
varied for each of the ﬁve models as follows: (i) S2; (ii) S2
and e (the eﬀective internal correlation time for fast
motions); (iii) S2 and Rex; (iv) S
2, Rex and e; (v) Sf
2, Ss
2
(the order parameter terms for longer and shorter time-
scale motions respectively), and e.
For this analysis, chemical shift anisotropies of 133 ppm
and 144 ppm were used for C8 of Guanine and Adenine,
respectively; a value of 212 ppm was used for C6 of Uracil
and Cytosine; 40 ppm was used for all sugar resonances
regardless of nucleotide type (32,33). A bond length of
1.09 A˚ was assumed for C10–H10 bonds, while the assumed
bond length for base resonances was 1.104 A˚ (32,33). We
assumed all chemical shift tensors were axially symmetric
(Z=0) and that the axis of symmetry of the chemical shift
tensor remained collinear with the C–H bond. The small
errors introduced by the aforementioned assumptions
have been discussed at great length in previous publica-
tions (16,30).
RESULTS
We executed a comprehensive study of the dynamics of
TAR bound to three diﬀerent ligands and compared these
results with the free RNA. The T1, T1r and NOE experi-
ments were recorded and analyzed as described in the
Methods section for the C10, C6 and C8 sites for free
TAR, and TAR bound to: (i) argininamide (Arg–TAR),
(ii) an 11-mer peptide derived from the basic binding
region of TAR and (iii) a cyclic peptide recently discov-
ered with unprecedented speciﬁcity and activity in viral
replication (unpublished results) (Figure 1). The cyclic
structure is closely related to a family of peptides that
we characterized as inhibitors of the Tat–TAR interaction
in BIV (11,21,34). Based on the similarity between BIV
and HIV Tat and TAR, we identiﬁed the structure of
Figure 1c as a potent (Kd=5nM) and selective inhibitor
of the Tat–TAR interaction in vitro that also inhibits viral
replication with sub-mM potency in infected human
lymphocytes.
The assignments of free TAR and of TAR bound to
argininamide were taken from previous studies (5,8);
assignments for TAR bound to the two diﬀerent peptides
were obtained by collecting 2D NOESY and 3D NOESY-
HSQC spectra, which were analyzed using previously pub-
lished methods (23–25). Typical T1 and T1r relaxation
decay curves for representative residues of the Arg–TAR
complex are shown in Figure 2. All relaxation decay
curves were well ﬁt by single exponentials, without any
evidence for multi-exponential relaxation. Some nuclei
were nonetheless excluded from the analysis of the relax-
ation data because the corresponding resonances were
overlapped in the spectra. The 13C relaxation properties
for all of the purine C8 (14/14) and nearly all of the
pyrimidine C6 (11/15) and ribose C10 (23/29) could be
measured and analyzed reliably for free TAR. For the
TAR–Arg complex, the relaxation properties for 12 of
the 14 C8 purines, 12 of the C6 pyrimidines and 21 of
the C10 ribose resonances were measured and analyzed.
Regarding the TAR complex with the linear Tat peptide,
relaxation properties were measured and analyzed for 12
C8 purines, 10 C6 pyrimidines and 22 C10 ribose reso-
nances. Finally, the relaxation properties of all 14 purine
C80s, 12 pyrimidine C60s and 25 C10 ribose resonances for
the TAR–cyclic peptide complex, were measured and ana-
lyzed. Figure 3 displays one set of relaxation parameters
for the riboses and the bases of the cyclic peptide–TAR
complex, respectively. Due to the large amount of data
that would have to be reported, the majority of the
observed relaxation times obtained from the analysis of
these decay curves and the heteronuclear NOE are
reported in the Supplementary Data.
The NMR structures for TAR and two of the TAR–
ligand complexes studied here (5,6,8,21) (corresponding to
Arg and the cyclic peptide, there is no structure for the Tat
peptide–RNA complex because of considerable residual
dynamics in the peptide itself) indicate the two double
helical sections form ideal A-form helices. These helices
are rigid and without signiﬁcant internal motion (6,30);
hence, the average values of T1, T1r and the heteronuclear
NOE observed in the helical regions of TAR in the
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diﬀerent complexes provide a reference point to assess the
presence of internal motion in other residues (35). Since
the helices are assumed to undergo only global motions,
the observed changes in average relaxation times between
complexes arise from changes in overall correlation time
due to increased molecular weight and/or from altered
hydrodynamic properties of the RNA when TAR changes
structure upon ligand binding.
The average relaxation values for the C10, C6, and C8
sites of the helical regions for free TAR and the three
TAR–ligand complexes are shown in Table 1. Although
the molecular size of the TAR–Arg complex is similar to
that of free TAR, it is well known (6) that binding argini-
namide to TAR changes the overall shape of the RNA.
This conformational change may very reasonably account
for the small increases in average relaxation times (15%
for sugars and 24% for bases) reported in Table 1. The
increases in relaxation times observed for the linear and
cyclic peptides reﬂect the increased molecular weight and
size of these complexes.
In this analysis, residues experiencing internal motions
are identiﬁed by comparing relaxation time to the average
values shown in Table 1. Residues exhibiting motion on
a fast (ns–ps) timescale are expected to yield relaxation
times, T1 and T1r, which are smaller and larger than
those average values for a rigidly tumbling molecule,
respectively. In addition, ps–ns motions will result in
larger than average NOE values, due to the dependence
of the NOE enhancement on the correlation time. Motion
on the ms–ms timescale (conformational exchange) can
also be identiﬁed from the relaxation data (yielding
lower than average T1r) and can be conﬁrmed by measur-
ing the power dependence of T1r. Based on these
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considerations, noteworthy trends that emerge from the
data are presented in the next section.
All three ligands induce similar changes in dynamics within
the bulge loop, but the cyclic peptide induce unique
dynamics within the apical loop
The results obtained for free TAR are consistent with pre-
vious studies (27,36,37), but it is worth recapitulating
them here because they provide a necessary reference.
Based on the relaxation data tabulated in the Supplemen-
tary Data and the principles described in the previous
section, we conclude that several ribose residues in free
TAR (U23, U31, G32, G33, G34, A35, G43 and C45)
exhibit fast motions on the ps–ns timescale. U23 is part
of the Tat-binding site and is critical for ligand binding,
while C24 and U25 act primarily as spacers (8). U31, G32,
G33, G34 and A35 are all parts of the apical loop, the
binding site of Cyclin T1 (38). G43 experiences increased
dynamics uncharacteristic of helical residues, for which we
have no explanation, while C45 is the terminal 30 residue
and experiences end-fraying motions that are well known
to occur in DNA and RNA. In addition, several of these
residues (C30, U31, G34 and A35) experience slower
motions (ms); these are also observed for A22, which is
adjacent to the Tat-binding site and C24 within the
bulge. Base resonances within the Tat-binding site (U23,
C24) and the apical loop (G32, G33, G34 and A35) also
have relaxation times consistent with the presence of fast
internal motions; unfortunately, the remaining residues in
the Tat-binding site and apical loop could not be resolved
from other resonances. Of the bases with well-resolved
resonances, G34 and A35 experience slower motions as
well (ms). Altogether, these data conﬁrm that the loop
bases have inherently higher ﬂexibility and are unlikely
to participate in any hydrogen bonding interactions with
other nucleotides.
Upon formation of each of the three complexes we have
studied, residues in the Tat-binding site experience consid-
erable changes in dynamics (Supplementary Data and
Figure 3). While both the base and ribose of U23
become more rigid in each complex, the base and ribose
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Table 1. The average relaxation times (ms) and heteronuclear NOE
values for the helical residues of unbound TAR and its three complexes
Site TAR Arg–TAR Tat11–TAR L22–TAR
T1 (ms)
C10 536 13 619 35 602 38 604 27
C6 354 14 441 16 468 18 429 25
C8 442 22 551 13 556 14 529 16
T1r (ms)
C10 37.2 0.4 29.1 0.6 26.1 0.6 29.5 0.7
C6 25.2 0.2 18.8 0.5 17.6 0.3 20.2 0.7
C8 31.0 0.3 24.5 0.7 22.0 0.3 25.3 0.7
NOE
C10 1.23 0.02 1.14 0.02 1.18 0.03 1.13 0.01
C6 1.16 0.02 1.13 0.02 1.09 0.02 1.10 0.02
C8 1.18 0.02 1.18 0.01 1.15 0.02 1.14 0.01
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of C24 become more mobile on the ns–ps timescale com-
pared to free TAR. U25 exhibits considerable motion in
the complexes on the ns–ps timescale as well; however,
comparison with the free RNA cannot be made for this
nucleotide because it is overlapped in free TAR. These
results are consistent with the structures of TAR showing
that U25 and C24 become extra-helical and structurally
unconstrained upon binding of argininamide or any
Tat-related peptide (5,6,39). In addition, the power depen-
dence data demonstrate that the slower motions experi-
enced by the C24 ribose are quenched in all complexes.
Ligand-speciﬁc changes in dynamics are clearly evident
in the apical loop as well (Supplementary Data and
Figure 3). However, while Arginineamide and the linear
Tat peptide complexes have similar dynamic proﬁles in the
loop, the cyclic peptide diﬀers from the other two ligands
and from free TAR. In the apical loop, all bases that are
resolved in the free form of TAR (G32, G33, G34 and
A35) become more rigid on the ns–ps timescale upon
ligand binding, with the exception of the A35 base in the
Arg complex which retains its ﬂexibility. For the Arg and
linear Tat peptide complexes, the ribose of C30 retains the
slow motions observed in the free form of TAR, while
U31 becomes rigid on the ns–ps timescale and continues
to exhibit motions on the ms timescale. While both G32
and G33 retain some ﬂexibility within their riboses, they
become more rigid than in the free form; however, G32
and G33 retain more ﬂexibility in the cyclic peptide com-
plex compared to the other complexes. Interestingly, the
cyclic peptide complex retains slower motions for nucleo-
tide A35, although these motions are quenched in the
Argininamide and linear Tat peptide complexes. Thus,
the RNA riboses in the TAR complex with the cyclic
peptide are more mobile than the other complexes for
residues G32, G33 and, on a diﬀerent time scale, for
A35. G32 retains motion on a ps–ns time scale in all
free and bound forms of TAR. Intriguingly, the C30
(resolvable in the Arg complex only) and U31 bases expe-
rience motions in both the Arg and linear peptide com-
plexes that are not evident in the cyclic peptide complex.
Model-Free analysis of the 13C relaxation data
In order to obtain more quantitative insight into the
changes in TAR dynamics occurring upon binding of
each ligand, the primary relaxation data were analyzed
with Model-Free to determine order parameters S2,
which describe local ﬂexibility for each individual site.
Despite the well-known limitations of this approach
(30,40,41), it represents a well-accepted ﬁrst approxima-
tion to the description of dynamics in proteins and, more
recently, of RNA as well (16,27,30).
The Model-Free analysis was performed for the eight
sets of relaxation data, for the bases and riboses, in order
to provide quantitative descriptions of the dynamic
changes upon ligand binding. The relaxation data for
non-terminal helical base pairs were ﬁrst used to deter-
mine an overall rotational correlation time, m, for free
TAR as well as the three complexes. Structures that
are not spherical require additional parameters describing
the asymmetric diﬀusion tensor, such as the angles
describing the axis of symmetry of the diﬀusion tensor,
in addition to the overall global tumbling time. This is a
simple task if a 3D structure is available. Upon analysis of
the data using two diﬀerent models (isotropic and axially
symmetric rotational diﬀusion based on the available
structures), the parameters extracted for both the sugar
and base resonances of free TAR, Arg–TAR and cyclic
peptide–TAR showed a diﬀerence of less than 5%. Thus,
the axially symmetric model was used when a structure
was available (free TAR, Arg–TAR and cyclic
peptide–TAR); in the case of the complex with the
Tat-derived linear peptide, for which no structure is avail-
able, the isotropic model was employed instead.
Global correlation times were calculated using Model-
Free 4.15 (31) with only non-terminal helical residues used
in the calculation. Free TAR was calculated to have
a rotational correlation time of 5.9 ns; this is similar to
RNAs of similar size; correlation times of 6.0 ns and
4.3 ns were obtained for the U1A protein-binding site
(30) and for HIV-2 TAR (36), respectively. Binding of
Arg (m=6.4 ns) does not increase the mass substantially,
but induces a signiﬁcant conformational change, which
may reasonably explain the slightly increased correlation
time. Binding of the cyclic and linear peptides results in
correlation times of 7.2 ns and 7.6 ns, respectively; these
values are close to what is expected from the increase
in mass.
The complete results of this analysis for all nucleotides
and all complexes are reported in the Supplementary
Data. In order to represent the substantial set of motional
parameters obtained from this analysis graphically and
concisely, residues have been color-coded according to
their observed S2 values on the structure of TAR and its
complexes in Figure 4.
For free TAR, the S2 values for riboses with double
helices (excluding terminal residues) range from 0.88 to
0.98, with an average of 0.93, while for the bases S2
values are between 0.89 and 0.97 with an average of
0.95. S2 values for the Arg–TAR complex range from
0.86 to 0.94 for the ribose and 0.79 to 0.98 for the bases,
with averages of 0.93 and 0.91, respectively. For the linear
peptide–TAR complex, S2 values for the riboses ranged
from 0.89 to 0.98 with an average of 0.93 and from 0.83 to
0.99 for the bases with an average value of 0.97. S2 values
for the cyclic peptide–TAR complex range from 0.92 to
0.99 for the ribose and 0.86 to 0.99 for the bases, with
average of 0.95 and 0.94, respectively. Thus, very similar
values of S2 are calculated for all complexes, within exper-
imental uncertainty, for all helical residues.
Quantitative analysis of the changes in dynamics
in TAR bound to the three ligands
Changes in ns–ps dynamics of TAR upon binding to each
of the three ligands are represented graphically in
Figure 4. In all cases, the bulge region displays signiﬁcant
increases in ﬂexibility for the two spacer residues, C24
and U25. In contrast, the loop region of all three com-
plexes becomes increasingly rigid, with the cyclic peptide
complex showing the greatest decrease in ﬂexibility in this
region.
1534 Nucleic Acids Research, 2009, Vol. 37, No. 5
Consistent with the qualitative analysis of relaxation
times reported earlier, U23 becomes more motionally
rigid in all three TAR complexes. The C24 base and
ribose both become more ﬂexible in each of the complexes;
the S2 values change from 0.7 and 0.9 in free TAR to
0.36–0.5 and 0.4–0.6 in the complexes. Although U25
cannot be analyzed in free TAR, both its base and
ribose are ﬂexible in the bound forms of TAR, with S2
of about 0.50 for the base and of between 0.64 (both pep-
tides) and 0.76 (Arg) for the ribose. These results are con-
sistent with the structure of the TAR complexes, since
binding of each of the three ligands pushes C24 and U25
outside of the helical structure of TAR (6,39).
The ns–ps dynamics of the apical loop are signiﬁcantly
more complex than those observed at the bulge. Further-
more, a large proportion of the resolvable residues in the
apical loop undergo conformational exchange on the ms
time scale resulting in a decrease in the transverse relaxation
time. The occurrence of conformational exchange has
previously been shown to inﬂuence the order parameters
extracted fromModel-Free (30). In such cases, a qualitative
analysis of theT1,T2 andNOE ratio (as shown earlier in the
article) is more accurate than Model-Free (30). Therefore,
the qualitative discussion presented above remains valid for
most loop residues. However, the order parameters of G32
and G33 are not inﬂuenced by conformational exchange
as they do not experience it. We observe that the order
parameters for G32 and G33 of free TAR (0.69 and 0.74
for base and ribose) increase for the cyclic peptide complex
(0.81 and 0.81), the Arg complex (0.83 and 0.91) and the
complex with the linear Tat peptide (0.87 and 0.92).
Conformational exchange
The data on the power dependence of T1r identify several
sugar residues in free TAR that experience conformational
exchange (Figure 5). Consistent with the qualitative and
Model-Free analysis of the relaxation data, these motions
primarily occur in the bulge C24 (7 s1) and within the
loop [U31 (7 s1), G34 (14 s1) and A35 (7 s1)]. Unlike
the relaxation data, however, no evidence of conforma-
tional exchange was found from the power dependence
studies for residue C30. Power dependence studies probe
a limited timescale, as slow as 300 ms with the spin-lock
powers used in this study, and it is likely that C30 experi-
ences instead motion outside of this timescale. Interest-
ingly, for the Arg complex, power dependence of T1r
was evident for the C30 ribose, implying that motions
on slightly diﬀerent timescales may occur for this residue
in these two states of TAR. In addition to C30, conforma-
tional exchange is also present for U31 (21 s1) and G34
(30 s1) when Arg is bound. In the cyclic peptide complex,
only residues G34 (25 s1) and A35 (14 s1) exhibit a clear
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Figure 5. Rex (s
1) as determined through T1r power dependence
experiments. Riboses are displayed in green; bases in purple for: (a)
unbound TAR; (b) Arg–TAR and (c) cyclic peptide–TAR complex.
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Figure 4. S2 values determined by Model-Free analysis are displayed as
a surface representation of the structure of TAR for the C10, C6 and
C8 sites. Residues that could not be analyzed due to spectral overlap
are shown in light grey. Sites exhibiting local motion are colored based
upon their S2 value and the corresponding color in the above scale:
(a) free TAR; (b) Arg–TAR; (c) linear peptide–TAR and (d) cyclic
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dependence of T1r on the spin-lock ﬁeld. Signiﬁcantly,
exchange rates for both complexes are 2–3-fold higher
than in free TAR.
Only two base resonances experience conformational
exchange in free TAR. Power dependence data indicate
that A35 (15 s1) undergoes conformational exchange.
The reduction in T1r is masked by fast motions and
not immediately obvious from the primary relaxation
data. Conversely, there is no evidence of conformational
exchange for the base of G34 from the power dependence
data. However, as with the C30 ribose, it is likely that the
intermediate motions are outside of the range probed by
the spin-lock experiments described here. Consistent with
these observations, conformational exchange for the G34
base has been previously described in the literature (37).
The T1r power dependence data indicate that the same
nucleotides in diﬀerent complexes experience distinct
motions on the time scale probed by these experiments
(Figure 5). In the Arg complex, the bases of residues
C30 (15 s1) and U31 (12 s1) undergo conformational
exchange; these motions are absent in the cyclic peptide
complex. Relaxation data suggest that residue G32 exhib-
its ms–ms motion in both the Arg and cyclic peptide com-
plexes; however, the power dependence of T1r is only
observed in the second case (19 s1), implying that these
slower motions occur on diﬀerent timescales. In both com-
plexes, A35 undergoes conformational exchange (28 s1
for Arg, 15 s1 for the cyclic peptide). Conformational
exchange is also observed for U23 (10 s1) and G34
(7 s1) in the cyclic peptide complex (Figure 5). Thus,
TAR is dynamically rich in the ms–ms time scale, and dif-
ferent ligands have distinct motions in this regime.
Ligand binding quenches inter-helical motions
Ligand-free TAR undergoes interhelical motions centered
around the bulge that cannot be discerned by relaxation
measurements because they occur at rates comparable
to the global rotational correlation time (14,27,42,43).
Binding of Arg quenches these motions (42). While it is
reasonable to assume that binding of either the linear or
cyclic peptides will have the same eﬀect, we nonetheless
examined helix-elongated TAR RNAs bound to these two
peptides to verify this hypothesis. To execute these experi-
ments, the stem 1 helix of TAR was elongated by an addi-
tional 22 base pairs: 20 AU base pairs plus two GC base
pairs at the end to promote transcription. NMR data were
only collected and analyzed on samples labeled with 13C
and 15N labeled only at guanidine and cytosine residues to
render the elongated stem invisible by NMR. Since varia-
tions in intensities of peaks in HSQC spectra report on the
overall dynamics of a particular labeled site (28,35), inten-
sities in HSQC spectra for each residue were normalized
for each nucleotide (G and C) independently. We analyzed
exclusively residues that do not exhibit internal motion,
since their presence would aﬀect the apparent intensity
of that resonance and could falsely indicate the presence
of domain motions.
Figure 6 displays three of the six data sets (the remain-
ing data are in the Supplementary Data) that were col-
lected on the elongated TAR constructs. In free TAR,
the resonances located in stem 1 (G21, C41 and C44)
have intensities signiﬁcantly lower than any of the reso-
nances located in either stem 2 or in the ﬂexible regions of
TAR (loop, bulge and terminal ends). Data for the riboses
(data not shown) reﬂect a similar trend, with peaks arising
from stem 2 being about twice as intense as those observed
in stem 1. These results agree with previous studies (27,28)
showing that helix 2 experiences signiﬁcant reorientational
motions about the TAR helical axis. As we anticipated,
binding of both linear and cyclic peptides reduces the dif-
ference in peak intensity between the two stem regions
signiﬁcantly (Figure 6b and c). The average diﬀerences
in peak intensities between stem 1 and stem 2 for the
bases and riboses of the linear peptide–TAR complex
were 0.12 and 0.06, respectively, and 0.08 for the bases
and 0.01 for the sugars for the cyclic peptide complex.
As previously observed for arginine (27,28), these data
are consistent with a signiﬁcant reduction in interhelical
motions upon ligand binding, since the diﬀerence in peak
intensity between the two helices in each of these com-
plexes is signiﬁcantly lower than in the bound form.
Consistent with this conclusion, when RDCs were
measured for the cyclic peptide complex for use in struc-
tural reﬁnement; no evidence was found for interhelical
motions. Namely, the two helical regions could be
described with a single set of orientational parameters
demonstrating that they are rigidly related to each other.
DISCUSSION
HIV-1 TAR RNA has been the subject of many studies
aimed at discovering speciﬁc inhibitor of its activity, but
until now it has not been possible to identify compounds
with the potency and speciﬁcity required to elicit strong
antiviral activity (5,10,21,34,44). It has been recently con-
vincingly suggested that these small molecules bind to
TAR by capturing pre-existing conformations that are
sampled perhaps rarely in free TAR (3,10,14,37). The
objective of the present work was to provide insight into
how dynamics of TAR changes upon ligand binding, and
if changes in dynamics correlate with the aﬃnity or speci-
ﬁcity of the interaction.
We have measured T1, T1r, the NOE ratio and T1r
power dependence for most C10, C6 and C8 sites for
three complexes of HIV-1 TAR RNA using 13C NMR
relaxation techniques. We have studied intrinsic motional
properties and changes in dynamics that occur upon bind-
ing of three ligands of diﬀerent aﬃnity and speciﬁcity.
Arginine binds weakly, with mM dissociation constant,
but induces the same conformation in TAR that is
observed in much more potent ligands (5). In contrast,
the linear 11-mer Tat-derived peptide binds strongly
(22); however, because it lacks any stable secondary struc-
ture, it also binds non-speciﬁcally to other RNAs (5).
Finally, the cyclic peptide has a highly ordered structure,
binds with much greater selectivity and, perhaps as a con-
sequence, has unprecedented antiviral activity amongst
Tat inhibitors (unpublished results). We observe that all
three ligands induce essentially the same dynamics within
the three nucleotide bulge that constitutes the site of
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interaction with Tat, and that is diﬀerent from what is
observed for free TAR. However, the much more speciﬁc
cyclic peptide alters the dynamics of the apical loop, the
binding site for the essential human co-factor Cyclin T1, in
a way that is distinct from the other ligands and from
unbound TAR.
Binding of each of the three ligands alters the dynamics
of the Tat-binding site to a similar extent
The primary relaxation data and their analysis using
Model-Free indicate that many residues in free TAR are
inherently ﬂexible. These observations are consistent with
other studies that have probed motions in free TAR
(27,36,37) and will therefore not be discussed at length;
they have been measured to provide a baseline to discuss
changes in motion upon ligand binding. We observe both
fast motions (ns–ps) as well as conformational exchange
(ms–ms) in a number of bases and sugars located in both
the bulge loop where Tat binds and within the apical loop
where cyclin T1 binds. These results indicate that the
apical loop of free TAR experiences considerable motions
on multiple time scales, as originally suggested in the ﬁrst
NMR study of this hairpin (7).
All three ligands induce similar changes in dynamics
within the Tat-binding site, although they diﬀer from
each other. This result surprised us; the linear Tat-derived
peptides, like all other Tat peptide and peptoid mimics
(45) studied by us in the past (5,6), remains highly ﬂexible
and devoid of stable secondary structure, while the cyclic
peptide is well-structured and forms a rigid b-hairpin in
the presence and absence of TAR (21,34). U23 becomes
more rigid, while C24 and U25 (which are both increas-
ingly extrahelical upon ligand binding) become highly
mobile. Slower motions in the ms time scale found in the
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ribose of C24 in the free form of TAR disappear in all
three complexes. Furthermore, interhelical motions cen-
tered on the bulge in free TAR (28,42) are essentially
quenched in each of the three complexes.
Binding greatly reduces interhelical motions of TAR
The data presented in this study demonstrate that binding
of each of the three ligands signiﬁcantly reduces the inter-
helical motions of TAR, as reported just for arginine in a
previous study (42). Perhaps the decrease in rigidity in C24
and U25 helps compensate for entropic losses associated
with the rigidiﬁcation of U23 and the freezing of the inter-
helical motions (28,42), in addition to providing a struc-
ture conducive to binding. These results agree well with
other observations regarding local dynamics in the area of
the bulge, where binding was seen to increase rigidity on
the ns–ps timescale (except for the extrahelical C24 and
U25), while also quenching the conformational exchange
present at C24. The loss of these motions is important as
the bulge region acts as a ﬂexible hinge between the two
stems in the unbound form of TAR.
The precise location of the dynamic hinge allowing
for the remarkable relative ﬂexibility of the two halves
of TAR remains unclear (27,28,46). Both the base
(S2=0.84) and especially the ribose (S2=0.63) of U23
have order parameters consistent with the presence
of ps–ns motions in free TAR, as does the base of C24
(S2=0.70). Although the corresponding ribose is rigid on
a ns–ps time scale, power dependence studies indicate the
sugar of C24 experiences a high degree of conformational
exchange which is not seen for U23. The riboses of U40
(S2=0.85), A22 (S2=0.89) and G26 (S2=0.89) also dis-
play lower than average order compared to other helical
residues. Thus, the ribose of C24 experiences slow confor-
mational exchange and is surrounded by a highly ﬂexible
U23 residue and C24 base, and both are near helical sites
with increased disorder compared to the remainder of the
molecule. Upon binding to any of the ligands in this study,
C24 becomes conformationally stable (no exchange),
while at the same time extrahelical and therefore ﬂexible
on a diﬀerent time scale (ns–ps). The base of U23 loses its
ﬂexibility and U40 rigidiﬁes as well upon binding (27), as
also do the riboses of A22 and G26.
Dynamic changes in the apical loop are ligand specific
In contrast to the behavior at the bulge, we observed dif-
ferent changes in apical loop dynamics for the three com-
plexes. Both riboses (U31, G32 and G33) and bases (G32,
G33, G34 and A35) become increasingly rigid on the
ns–ps timescale and ligand binding induces ms motions
for the G32 base in all complexes. These results are sur-
prising; while the linear peptide may very well have a foot-
print that extends to the apical loop, binding of Arg
should only occur near the UCU bulge. We do not
attribute these changes to the quenching of interhelical
domain motions. In the free TAR, domain motions
occur at a rate comparable to rigid rotational diﬀusion
and are therefore not discernable in the relaxation experi-
ments (16,27,47). In both complexes, these motions are
simply quenched. It is possible that a secondary binding
site forms for Arg in the apical loop of TAR, resulting
in the stabilization of several apical loop residues. Alter-
natively or in addition, changes in the structure and
dynamics of the bulge loop are transmitted to the apical
loop by an unknown molecular mechanism.
The analysis of the relaxation times and power depen-
dence data indicate nevertheless that arginine and the
linear Tat peptide mimic induce similar changes in apical
loop dynamics. The C30 (resolved only in the Arg com-
plex) and U31 bases experience motions in both the Arg
and linear peptide complexes that are not evident in the
cyclic peptide complex. In addition, the A35 base of both
complexes remains highly ﬂexible, likely as a result of the
A35 ﬂipping completely outside of the loop in the bound
structure. This result contradicts observations made for
the cyclic peptide complex, where the A35 base is rigid.
This last complex nonetheless retains more ﬂexibility than
the other complexes for several ribose residues. Thus,
the linear Tat-derived peptide binds to the apical loop of
TAR in a manner closer to Arg than to the cyclic peptide,
despite the similarity in size and aﬃnity to the latter. These
dynamic diﬀerences are also reﬂected in the structure of
the corresponding complexes. Interactions with the apical
loop of linear Tat-peptides were never stable enough to
lead to well-deﬁned loop conformation or intermolecular
contacts. In contrast, the cyclic peptide interacts in a well-
deﬁned manner with the apical loop, leading to the obser-
vation of numerous intermolecular interactions and a new
loop structure (unpublished results).
While the cyclic peptide signiﬁcantly rigidiﬁes the apical
loop on the ns–ps timescale, it does not quench motions
that occur on the ms–ms timescale and that are observed in
the relaxation and especially in the power dependence
data. For example, the timescale of motion for the G32
residues in the apical loop for this complex diﬀers from the
other complexes (G32 exchanges at a high rate, 19 s1).
We interpret these results as indicative of a signiﬁcantly
diﬀerent structure and dynamic proﬁle of the TAR loop
when in complex with the cyclic peptide, potentially a very
important feature with regards to inhibition of the activity
of TAR in recruiting the cdk9 kinase to the HIV-1
promoter.
CONCLUSIONS
We have observed that binding of ligands of diﬀerent
aﬃnity and speciﬁcity to TAR alters its conformational
dynamics over a range of timescales. Regardless of the
nature of the ligand, all complexes induce a much more
rigid conformation for residues that make critical contacts
with TAR (U23 and the nearby double helical residues),
while increasing ﬂexibility at bulge residues C24 and U25.
This result surprised us, because linear peptides bind to
TAR in a disordered conformation without forming a
stable secondary structure, while the cyclic peptide forms
a well-deﬁned and rigid b-hairpin conformation. Thus,
ligand binding does not simply eliminate motions, but
instead leads to the formation of a new motional land-
scape that appears to be common to all peptidic ligands
that mimic Tat. These changes in structure and dynamics
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also lead to the quenching of the interhelical motions
observed in the ligand-free form of TAR. Examination
of the apical loop where cyclin T1 binds indicates that
the complexes with Arg and with the linear Tat mimic
were very similar to each other, but distinct from the sig-
niﬁcantly more speciﬁc cyclic peptide. The unique proﬁle
in loop dynamics, together with the observation of unique
intermolecular interactions with the apical loop, identi-
ﬁes the cyclic peptide as representative of a new class of
ligands capable of interacting with the apical loop of TAR
diﬀerently from other previously known peptide mimics of
Tat. The unprecedented activity of this cyclic peptide in
inhibiting viral replication may at least in part be due to its
ability to interfere not just with binding of Tat to TAR,
but also to the interaction of cyclic T1 with the TAR
apical loop.
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